Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | STLA | TSLA |
|---|---|---|
| Price | $4.34 | $356.22 |
| Change today | ▼ 0.46% | ▲ 0.40% |
| Market cap | $12.59B | $1.41T |
| Return, 3 months | -25.3% | -16.2% |
| Return, year to date | -60.1% | -20.8% |
| Return, 1 year | -55.0% | -22.5% |
| P/E (TTM) | -0.6 | 329.8 |
| P/B | 0.2 | 16.2 |
| P/E percentile vs own 5y | 23rd | 86th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +13.1% | +25.5% |
| Net profit growth (YoY) | +115.7% | -5.2% |
| Gross margin | 0.7% | 18.9% |
| Operating margin | -11.8% | 4.6% |
| Net margin | -12.1% | 3.7% |
| Return on equity | -29.0% | 4.6% |
| Analyst target vs. price | +38.7% | +17.3% |
| Analyst buy share | 0% | 50% |
| RSI (14) | 30 | 46 |
| 30-day volatility | 47.5% | 44.9% |
| Max drawdown, 1 year | -64.0% | -39.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
